Search Results 1011-1020 of 11398 for anti-TNF drugs

  1. A Study To Evaluate The Safety And Effectiveness Of Felzartamab In IgA Nephropathy - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search tips ... anti-CD38 antibody Felzartamab in patients with ...

  2. Phase Ib Study Of Select Drug Combinations In Patients With Lower Risk MDS - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Testosterone cypionate (intramuscular route) - Side effects & uses - Mayo Clinic

    An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

  4. A Study Of Enfortumab Vedotin Alone Or With Other Therapies For Treatment Of Urothelial Cancer - Mayo Clinic

    The purpose of this study is to test an experimental drug (enfortumab vedotin) alone and with different combinations of anticancer therapies. Pembrolizumab is ...

  5. A Study To Evaluate TVB-2640 And Trastuzumab Plus Paclitaxel Or Endocrine Therapy For Treating Patients With HER2 Positive Advanced Breast Cancer - Mayo Clinic

    FASN inhibitor TVB-2640 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as ...

  6. Trametinib, Combination Chemotherapy, And Radiation Therapy In Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery - Mayo Clinic

    Drugs used in chemotherapy, such as carboplatin and paclitaxel, work in ... Other anti-cancer therapy while on study treatment. megestrol [Megace] if ...

  7. Nateglinide (oral route) - Side effects & dosage - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  8. Study Of Durvalumab And Tremelimumab As First-line Treatment In Patients With Advanced Hepatocellular Carcinoma (HIMALAYA) - Mayo Clinic

    The purpose of this study is to assess the effectiveness and safety of durvalumab plus tremelimumab combination therapy and durvalumab monotherapy versus ...

  9. Rifaximin For The Treatment Of Gastrointestinal Toxicities Related To Pertuzumab-Based Therapy In Patients With Stage I-III HER2 Positive Breast Cancer - Mayo Clinic

    Rifaximin For The Treatment Of Gastrointestinal Toxicities Related To Pertuzumab-Based Therapy In Patients With Stage I-III HER2 Positive Breast Cancer. Print ...

  10. Treatment For CI-DME In Eyes With Very Good VA Study - Mayo Clinic

    The investigators do not know definitively whether eyes with central-involved DME and good vision do better with anti-VEGF (vascular endothelial growth factor) ...